Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22700,99,1.15 [0.81-1.62],0.4316265627360406
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23310,176,1.08 [0.82-1.42],0.5994548152867804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23077,1126,1.06 [0.95-1.18],0.3092097520529731
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23333,401,0.98 [0.81-1.19],0.8702966789378482
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22608,2940,1.03 [0.97-1.11],0.3325128294257243
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22812,2390,1.01 [0.93-1.09],0.8689395552445847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23096,1139,1.02 [0.91-1.14],0.7228472442781603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23240,77,0.86 [0.54-1.39],0.545625846855765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21795,667,1.01 [0.88-1.18],0.8450129174169198
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21059,769,1.08 [0.94-1.23],0.2657019019710042
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21116,213,1.15 [0.91-1.46],0.2540858526579606
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16371,1378,1.03 [0.93-1.14],0.5774839994283554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20929,308,1.06 [0.86-1.30],0.5983411600647177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23281,1324,1.05 [0.95-1.17],0.3130677756287331
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23386,454,0.99 [0.83-1.19],0.9304938341044652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22745,794,1.07 [0.94-1.22],0.3025802437434003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23337,736,1.05 [0.92-1.21],0.4475777088778805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22133,176,1.08 [0.82-1.43],0.568651616314951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23442,38,0.68 [0.33-1.41],0.2987696028793548
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23247,646,1.03 [0.89-1.20],0.6672754034769375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23237,74,1.32 [0.92-1.91],0.135404613438749
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23357,159,1.04 [0.77-1.40],0.800490295967489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23342,144,1.01 [0.73-1.40],0.9432419605833636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22242,291,1.08 [0.88-1.34],0.4544458839309444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22170,219,0.89 [0.68-1.18],0.4258601926028951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22053,96,1.21 [0.86-1.70],0.2788647017608671
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23419,33,0.97 [0.48-1.99],0.9416065800412866
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23375,138,1.21 [0.90-1.61],0.2033622585031578
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral warts,23275,38,1.41 [0.87-2.29],0.1666105326032078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23308,71,0.96 [0.60-1.53],0.8541097998672028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23206,203,0.92 [0.69-1.22],0.5596153928587753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23352,59,0.88 [0.51-1.51],0.6343586689117428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23344,59,1.14 [0.71-1.82],0.5917729127609563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23198,1018,0.96 [0.85-1.09],0.5408169756847381
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of meninges,23417,72,1.33 [0.93-1.91],0.1214883999695384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23383,59,1.04 [0.64-1.70],0.8691204972374712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23412,112,0.63 [0.41-0.98],0.0412442835006697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of ovary,23372,146,1.27 [0.97-1.66],0.08591394335153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23423,227,1.12 [0.89-1.42],0.3232317821447809
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Caecum,23428,205,0.94 [0.71-1.24],0.649731818206639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23363,53,1.14 [0.69-1.87],0.6039092551441325
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,23427,125,0.82 [0.56-1.21],0.3173910284034755
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23389,230,0.97 [0.75-1.26],0.8340600467071929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23348,427,1.07 [0.90-1.28],0.4431594745763257
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23428,243,0.91 [0.70-1.18],0.4901001415758655
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Carcinoma in situ of breast,18997,118,1.13 [0.81-1.57],0.4745662018956919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19065,134,1.02 [0.73-1.42],0.9101506871406864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19061,30,1.38 [0.79-2.39],0.2541777303979342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19088,57,1.22 [0.78-1.90],0.3830983756350601
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23382,120,1.10 [0.78-1.53],0.5926552471859574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",23383,118,1.12 [0.81-1.56],0.4950420748041442
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,22591,487,1.21 [1.03-1.41],0.0221007018276456
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lung cancer and mesothelioma,16825,274,0.98 [0.77-1.23],0.8385270019622274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lymphoid leukaemia,19064,33,1.03 [0.53-1.99],0.927852506780798
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19182,151,0.96 [0.70-1.33],0.8170891958648943
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19124,93,0.87 [0.57-1.34],0.5325000774847237
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19195,164,1.04 [0.78-1.39],0.774279296643321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19090,59,1.10 [0.69-1.74],0.6953710469937848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19090,59,0.62 [0.34-1.13],0.1203977220822196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19078,47,0.98 [0.56-1.72],0.9488998222151772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19159,128,1.08 [0.78-1.49],0.6568398700651663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19122,91,1.11 [0.76-1.62],0.5916481032388632
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19103,72,1.16 [0.77-1.73],0.4820837522243035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19066,35,0.99 [0.51-1.91],0.9804773085734756
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19101,70,0.76 [0.45-1.29],0.3141414304659289
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,23213,204,1.13 [0.88-1.45],0.3461455790219118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of trunk,23402,69,1.24 [0.82-1.87],0.3057262818483796
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanoma in situ,19060,77,0.89 [0.56-1.42],0.6236157966500153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19102,71,1.20 [0.81-1.79],0.365016873167993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19162,131,1.24 [0.93-1.65],0.1505373853647682
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19229,198,1.00 [0.76-1.32],0.9881370745030308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19112,81,1.20 [0.83-1.76],0.3334723292783322
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,23252,146,1.19 [0.89-1.58],0.231417266825439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19814,783,1.15 [1.01-1.30],0.0317968859793126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19847,816,1.14 [1.01-1.29],0.0352106162648497
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23160,330,1.21 [1.01-1.46],0.0423543533140751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21738,81,1.24 [0.85-1.80],0.2625679320833562
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22899,69,0.99 [0.62-1.59],0.9751994042874248
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22569,2514,1.07 [1.00-1.16],0.0591037640009644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22068,27,0.93 [0.43-2.03],0.8619714772680314
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23101,44,0.80 [0.41-1.53],0.4945760192260007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22943,1286,1.07 [0.96-1.19],0.2104093938639484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22943,1286,1.07 [0.96-1.19],0.2104093938639484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21724,67,1.40 [0.97-2.03],0.0734476811908604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23091,1050,1.12 [1.00-1.25],0.0453784127002837
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23158,101,1.24 [0.89-1.72],0.2108851797902972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22874,44,0.63 [0.32-1.27],0.1978239215556993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22884,54,0.78 [0.43-1.42],0.4239044572030233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23259,202,1.16 [0.91-1.48],0.2266226179649212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23347,51,0.91 [0.51-1.62],0.7512397034397293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23230,173,1.23 [0.96-1.58],0.1037188572505098
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22147,106,1.26 [0.92-1.74],0.1496141178809393
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18901,201,1.09 [0.84-1.40],0.5108985364947698
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22214,57,0.70 [0.39-1.25],0.2290762747133815
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22211,54,0.69 [0.38-1.27],0.2315382571883982
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18743,43,0.82 [0.43-1.56],0.5389756678297967
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21494,51,0.99 [0.57-1.71],0.9694703408319711
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21209,200,1.20 [0.94-1.53],0.1541866462318628
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23066,415,1.07 [0.89-1.28],0.46527804890129
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22904,253,0.96 [0.75-1.23],0.726215096880614
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22712,61,1.59 [1.14-2.21],0.0061524019500518
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23118,1675,0.94 [0.86-1.04],0.24611413023269
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20777,1637,0.94 [0.85-1.03],0.1919925566432355
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18745,45,1.53 [1.05-2.23],0.0250386201586258
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20852,101,0.88 [0.59-1.33],0.5523401071453786
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18936,236,0.95 [0.73-1.23],0.6828694737430108
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18743,43,0.67 [0.33-1.33],0.2509950087556905
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21382,2682,0.95 [0.88-1.03],0.1904953608100793
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18879,179,0.96 [0.72-1.28],0.7761161901650101
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19161,461,1.02 [0.85-1.21],0.8637395138412962
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23361,304,1.00 [0.80-1.25],0.9811324427909895
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23197,140,0.96 [0.69-1.34],0.8042484362210587
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18783,83,1.24 [0.87-1.76],0.2390413335922619
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18749,49,1.21 [0.76-1.94],0.4276708957066232
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22692,1941,0.99 [0.90-1.08],0.7879075408109273
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18869,169,1.10 [0.84-1.44],0.5049485194699095
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18870,170,1.18 [0.91-1.52],0.2198613563257649
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19157,457,0.96 [0.80-1.15],0.6662766052721331
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18766,66,1.05 [0.66-1.65],0.8466338432279329
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23191,134,0.91 [0.64-1.29],0.5961237284035996
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19218,518,1.01 [0.86-1.20],0.8876963741218863
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19174,474,1.02 [0.85-1.21],0.8652373047329448
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21070,61,1.69 [1.22-2.33],0.0015036085773324
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22699,3999,0.99 [0.94-1.06],0.8533634501608721
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20813,62,0.72 [0.40-1.28],0.2565890855251659
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20827,76,0.93 [0.59-1.48],0.7632676826255913
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23279,1754,1.01 [0.92-1.11],0.8488549304197214
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23283,1753,1.01 [0.92-1.11],0.8480728167506353
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20823,72,0.80 [0.48-1.33],0.3923997260934536
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23089,1345,0.99 [0.89-1.10],0.7911079123783401
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19967,1267,1.03 [0.93-1.15],0.5334154610359387
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23432,152,0.84 [0.60-1.19],0.3322800104583837
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22691,40,1.08 [0.61-1.93],0.7876125752557656
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21861,117,1.17 [0.86-1.61],0.3215893332518454
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21914,170,0.75 [0.53-1.05],0.0913959162483385
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18918,218,1.08 [0.84-1.38],0.5487392812840086
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21892,119,0.82 [0.56-1.20],0.3094746238410281
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1441,37,0.80 [0.40-1.57],0.5151713790715085
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1537,150,1.00 [0.72-1.38],0.9891500503474174
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21797,24,0.61 [0.24-1.54],0.293890697619752
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1425,22,1.08 [0.49-2.37],0.8433423209687871
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23036,1263,0.88 [0.79-0.99],0.0374415047656339
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22940,289,1.02 [0.82-1.28],0.8292800695837955
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21421,412,0.99 [0.81-1.20],0.8817504333653332
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19297,597,1.05 [0.90-1.22],0.5384750005296934
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23360,205,1.09 [0.84-1.40],0.5255218939486539
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22558,43,0.81 [0.42-1.56],0.5232664279722747
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,22152,735,1.13 [0.99-1.29],0.064718375854269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22592,77,1.17 [0.79-1.73],0.4392799693971436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22543,28,1.26 [0.66-2.40],0.4778051889528596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22654,139,0.99 [0.71-1.38],0.9602668348269102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15247,1235,1.06 [0.95-1.18],0.319820612596039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,AV-block,20571,205,0.98 [0.75-1.28],0.866194906991835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23401,260,0.95 [0.74-1.21],0.6759293684384261
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,14118,106,1.08 [0.74-1.57],0.7059222978010609
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20485,119,0.90 [0.62-1.31],0.5766407037344847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20438,72,0.87 [0.53-1.43],0.594387955908791
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23439,27,1.00 [0.49-2.07],0.9899894042390012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,20975,609,0.94 [0.80-1.11],0.4669261995938798
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22671,1265,1.12 [1.02-1.24],0.022171689394052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21110,6213,1.01 [0.96-1.06],0.8224538850192715
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22171,218,1.11 [0.87-1.42],0.4077534351407278
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Endocarditis,20412,46,1.13 [0.66-1.91],0.6578844279613782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23355,705,1.08 [0.94-1.24],0.2723372784447878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,21636,5228,1.01 [0.96-1.07],0.5856296958433189
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21643,5235,1.01 [0.96-1.07],0.6005329969146325
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23342,35,1.20 [0.68-2.10],0.530267006189725
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16555,147,1.13 [0.85-1.50],0.4135848116965268
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16471,63,0.84 [0.50-1.42],0.5234519781363607
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,23329,900,1.06 [0.94-1.20],0.3259114854756342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22796,84,1.02 [0.67-1.56],0.9093496894307572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22844,1427,1.13 [1.03-1.24],0.0092705237086073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23175,391,0.99 [0.81-1.21],0.9289180396979296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20624,258,0.85 [0.65-1.10],0.2153017351472098
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23258,513,1.05 [0.89-1.23],0.5875067897199902
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21825,408,1.07 [0.89-1.28],0.4576143363349326
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23419,76,1.34 [0.94-1.91],0.1022787949410885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23434,203,1.20 [0.95-1.52],0.1304556593423048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,21987,34,1.01 [0.52-1.95],0.9827230968103704
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other aneurysm,22565,50,1.06 [0.63-1.80],0.8143131689976907
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,20678,312,0.97 [0.78-1.21],0.7910616855055972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22573,58,1.19 [0.76-1.88],0.4446950801870112
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22684,169,1.02 [0.76-1.37],0.901152960893694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20511,145,0.96 [0.69-1.34],0.817932303855908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,22028,75,1.25 [0.84-1.85],0.2700500212064219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21994,41,1.54 [0.99-2.41],0.0564156538440454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22370,32,0.68 [0.30-1.52],0.3429408986057782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22088,135,1.03 [0.74-1.43],0.8642377268180707
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21027,661,1.12 [0.98-1.29],0.099524121072969
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22465,36,0.94 [0.48-1.83],0.8551947085300659
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22953,438,1.00 [0.83-1.21],0.9740988859842246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22940,279,1.20 [0.98-1.46],0.0796864500033357
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22795,457,1.09 [0.92-1.29],0.346150835864361
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14260,248,1.03 [0.80-1.32],0.8190870014888075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22746,241,0.97 [0.75-1.25],0.8195116589342966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22234,281,1.16 [0.93-1.43],0.1857994530121683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23040,379,1.19 [1.00-1.42],0.0445743308430589
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23371,489,1.03 [0.87-1.22],0.7109123908449286
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20543,177,1.11 [0.85-1.45],0.4446104512634106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22934,273,1.21 [0.99-1.48],0.0596941678581451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22471,133,0.98 [0.70-1.37],0.8877730290993732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23167,455,0.99 [0.83-1.19],0.948703869368541
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23145,495,1.02 [0.86-1.21],0.8358317200845478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22767,62,0.93 [0.55-1.56],0.7810230600163433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22550,35,1.35 [0.82-2.22],0.2394829421072496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22961,177,0.92 [0.68-1.25],0.6132317136799521
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22918,173,0.94 [0.69-1.27],0.6876878300810971
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,22321,368,1.20 [1.00-1.43],0.0471667829768977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22526,83,0.61 [0.36-1.01],0.056432236704246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23261,600,1.16 [1.01-1.34],0.0336642558234739
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23403,194,0.84 [0.62-1.13],0.2490932910880972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20820,1571,0.97 [0.88-1.07],0.5010124565558565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,22933,3684,0.93 [0.87-1.00],0.0366839327224261
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23378,227,0.81 [0.61-1.08],0.149963025900783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20938,1689,0.94 [0.85-1.03],0.1749345924234493
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19323,74,0.92 [0.58-1.46],0.7183033723320913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,23102,1021,0.92 [0.81-1.05],0.2302117270066477
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20435,1186,0.89 [0.79-1.00],0.0555740196076381
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Vascular dementia,23024,91,1.05 [0.71-1.55],0.803522658974068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Alzheimer disease,23440,314,0.93 [0.74-1.16],0.5152414892705393
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16055,53,1.20 [0.75-1.93],0.4485635360230293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Bell's palsy,21599,71,1.00 [0.63-1.58],0.9937217394574293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22078,550,0.95 [0.80-1.12],0.5506125556552144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral cysts,23099,187,0.93 [0.70-1.25],0.638354683628652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23380,234,0.96 [0.74-1.24],0.7548649090151172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23031,38,1.56 [1.03-2.37],0.035873037762315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23429,40,1.48 [0.96-2.27],0.0731466323477033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22956,44,1.03 [0.59-1.82],0.9154992450597046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,22207,242,0.73 [0.55-0.97],0.0313717533694569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23083,1118,0.93 [0.83-1.05],0.2659920420076865
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23397,303,1.02 [0.82-1.27],0.8258878996527688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22909,2465,1.03 [0.96-1.11],0.3911819825713852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,23129,42,0.78 [0.39-1.53],0.4635376930401327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,23331,185,0.97 [0.73-1.29],0.8283875631049818
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hydrocephalus,22966,54,0.76 [0.42-1.38],0.3691284813181301
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23422,67,1.44 [1.01-2.06],0.0463687857638676
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21638,110,0.87 [0.59-1.30],0.4978962550133891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21584,56,0.76 [0.42-1.36],0.3524703944346732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Memory loss,22914,91,0.88 [0.57-1.36],0.5670795925282734
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,22393,428,1.11 [0.93-1.32],0.2470291441061514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23343,391,1.09 [0.90-1.31],0.3844710545632043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Motor neuron disease,16141,115,1.09 [0.78-1.53],0.6210843344127464
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23242,119,1.06 [0.75-1.50],0.7537152778812712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22726,1198,1.03 [0.92-1.15],0.6036410082761438
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,22056,3151,1.00 [0.94-1.07],0.9502646105107352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23112,119,1.10 [0.80-1.53],0.5491314656177616
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21886,358,1.12 [0.92-1.35],0.2502662532208731
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23390,192,0.78 [0.57-1.06],0.1101571553251576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18956,559,1.06 [0.90-1.24],0.4786368840582264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22971,59,0.76 [0.43-1.35],0.3443427984492723
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23020,108,1.03 [0.71-1.48],0.8917573991752692
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23236,142,1.04 [0.76-1.43],0.8004491952873478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21607,79,1.08 [0.71-1.63],0.7280137904354089
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other headache syndromes,22031,66,0.84 [0.50-1.43],0.5238343415652044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23342,430,0.93 [0.77-1.13],0.4836679719951426
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,22305,340,0.93 [0.75-1.16],0.5316960377804205
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Parkinson's disease,23418,144,1.13 [0.85-1.52],0.4035929122121606
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22982,70,1.03 [0.66-1.63],0.8874806248010224
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,23439,76,1.00 [0.65-1.55],0.9984488783792967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23291,273,0.88 [0.68-1.12],0.2938915720936821
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23231,33,1.09 [0.58-2.07],0.7867324459109752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23430,140,1.02 [0.74-1.40],0.910923269638584
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21588,60,1.33 [0.90-1.97],0.1574868003209757
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23440,317,0.92 [0.73-1.15],0.4571275319857566
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22984,88,1.04 [0.70-1.55],0.846571022135125
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22937,94,0.92 [0.61-1.39],0.6957654422417741
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23044,421,1.01 [0.84-1.22],0.8837914051150503
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23315,142,0.89 [0.63-1.25],0.4939315992671225
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22494,51,0.94 [0.54-1.64],0.8320772958782738
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22489,46,0.76 [0.40-1.46],0.4069957350828482
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23332,57,1.11 [0.70-1.78],0.6562002848341236
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23201,148,0.96 [0.69-1.32],0.7909031213803115
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1432,28,1.07 [0.53-2.13],0.8547365458851786
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1721,53,0.78 [0.43-1.40],0.3976142022210966
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22927,84,0.97 [0.63-1.48],0.8822661309047266
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23291,900,0.93 [0.81-1.06],0.2958954427876324
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23080,637,1.07 [0.92-1.23],0.3916437004771411
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22703,260,1.01 [0.79-1.28],0.9357923961723252
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23366,743,1.00 [0.87-1.15],0.9842951262174472
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23428,61,1.48 [1.04-2.12],0.0300352821529682
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23299,676,1.03 [0.89-1.19],0.6950308373823213
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23402,349,1.00 [0.81-1.23],0.9994718328900706
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23356,177,1.17 [0.89-1.52],0.2613288518997337
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22478,35,1.29 [0.76-2.19],0.352936259516094
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22483,40,0.76 [0.38-1.51],0.4303529884417334
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22504,61,0.80 [0.46-1.39],0.4231476889180484
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23365,605,0.96 [0.82-1.12],0.5983867247010353
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22904,144,1.15 [0.86-1.54],0.3467975956095523
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22679,56,0.70 [0.38-1.28],0.2434192995802352
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23138,85,0.99 [0.66-1.51],0.9770234979410504
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23326,273,0.98 [0.78-1.24],0.8847612766559572
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22805,182,1.20 [0.93-1.54],0.1657344107760822
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23292,113,1.30 [0.96-1.76],0.0868530304536368
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23154,394,0.92 [0.75-1.13],0.4140048693830335
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22977,134,0.97 [0.68-1.36],0.8417945125533856
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21910,2177,1.03 [0.95-1.12],0.434213132654612
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23295,242,0.92 [0.71-1.19],0.502127296780553
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23418,140,1.05 [0.77-1.45],0.7412048225870321
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22769,326,1.12 [0.92-1.37],0.2473234864850559
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23107,54,1.30 [0.86-1.98],0.2110978233829895
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23415,48,1.49 [1.01-2.21],0.0448862159360216
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22527,84,1.46 [1.08-1.97],0.0127547810848185
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22570,127,1.40 [1.08-1.81],0.0101357068469598
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22483,92,1.05 [0.71-1.56],0.7917906454403498
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22681,58,0.64 [0.35-1.17],0.1439802038191476
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22447,56,0.92 [0.53-1.59],0.7576493928745305
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22860,100,0.79 [0.51-1.22],0.2902660741218971
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22912,152,1.03 [0.76-1.40],0.8467955197370356
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22553,110,0.79 [0.52-1.19],0.2612829075763632
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22470,79,0.55 [0.32-0.93],0.0273498626098914
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22450,59,1.11 [0.69-1.78],0.678857290421912
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21515,1782,0.96 [0.88-1.06],0.4188389072448159
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22521,78,1.16 [0.78-1.72],0.4714432880012005
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23218,375,0.99 [0.81-1.21],0.9381450450844327
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22880,37,0.92 [0.47-1.79],0.7957931288876043
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22986,143,0.94 [0.67-1.31],0.709541644506371
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23222,96,0.78 [0.50-1.21],0.2657803954265637
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23401,92,1.12 [0.77-1.63],0.5651556368905313
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23338,123,0.80 [0.54-1.18],0.2602295308277383
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23186,60,0.93 [0.55-1.57],0.7795713174056282
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23189,63,1.20 [0.78-1.84],0.4020458950957665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23347,683,0.99 [0.86-1.15],0.913264616737625
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23133,469,1.12 [0.95-1.32],0.1656073586821639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22762,98,0.90 [0.59-1.36],0.6056522376189168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22738,74,0.88 [0.54-1.41],0.5864285471195937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23202,74,1.10 [0.72-1.68],0.647253767929932
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23331,203,1.01 [0.77-1.32],0.9618325568732312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23184,56,1.02 [0.61-1.70],0.9531911848476282
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza,22001,107,0.98 [0.68-1.43],0.9330704488440782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22000,106,0.98 [0.68-1.44],0.9363519525517784
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16666,115,0.89 [0.61-1.30],0.5425847751767134
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23318,242,0.87 [0.67-1.14],0.3169253625623542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18198,1803,1.02 [0.93-1.11],0.7322104277563046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18331,1780,1.02 [0.93-1.11],0.6921965530212151
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23088,114,0.86 [0.58-1.28],0.4654110945978723
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21956,62,0.76 [0.43-1.34],0.3397992521300436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bronchiectasis,20226,343,0.99 [0.80-1.23],0.9569929293244916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19942,59,1.15 [0.73-1.81],0.5515367329600216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22450,2567,1.03 [0.95-1.11],0.4852014001499874
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22347,57,1.36 [0.90-2.04],0.1403930676537889
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22413,123,1.27 [0.95-1.70],0.1048412225457726
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23297,882,1.10 [0.97-1.24],0.1356386412963375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22353,63,0.88 [0.53-1.49],0.6426095281364264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21648,4401,1.01 [0.96-1.07],0.6633629356872149
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22580,290,0.83 [0.65-1.07],0.1454273651534275
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,22692,277,1.13 [0.91-1.40],0.2801613118087807
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Emphysema,20108,225,1.06 [0.82-1.36],0.6577358411662281
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21994,193,1.08 [0.83-1.41],0.5453876531133721
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23274,1380,1.03 [0.93-1.14],0.5685150231196392
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22030,229,1.18 [0.95-1.48],0.1401950287394839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Later onset COPD,22651,605,1.09 [0.94-1.27],0.2367625617902586
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23434,188,0.80 [0.59-1.10],0.1692335177237069
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,22348,58,1.44 [1.00-2.07],0.0478219224045149
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23241,796,1.09 [0.96-1.24],0.1829333530932766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23280,1490,0.98 [0.89-1.09],0.7322085272585153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22961,671,0.98 [0.84-1.14],0.8027998770395695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other pleural conditions,21823,33,0.90 [0.45-1.83],0.7754105827896245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23368,290,1.12 [0.91-1.38],0.2747437965304347
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23360,1017,0.99 [0.88-1.12],0.870323209834955
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,22498,708,0.99 [0.85-1.14],0.8663168626149426
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural plaque,21829,39,1.47 [0.96-2.23],0.0731027053406092
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23068,1174,1.06 [0.95-1.18],0.2896859815339565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23409,163,0.76 [0.54-1.07],0.1123988660260073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumothorax,21877,87,1.02 [0.68-1.54],0.9060988943680932
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pollen allergy,23415,203,0.87 [0.65-1.17],0.3600645607969778
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,23131,53,1.03 [0.62-1.72],0.900034023494379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16592,41,1.06 [0.60-1.84],0.8500905633450558
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23222,777,1.10 [0.97-1.25],0.1333384142905156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22532,242,0.87 [0.67-1.14],0.3123469900026039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Viral pneumonia,22073,179,0.89 [0.65-1.21],0.4474392203956141
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23097,141,0.84 [0.59-1.20],0.3478701964928505
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11304,90,0.78 [0.49-1.25],0.3036576855312353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16784,33,0.55 [0.24-1.25],0.1533912330718561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23275,120,1.16 [0.85-1.60],0.3472438433662417
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute gastritis,17602,70,1.23 [0.83-1.81],0.3037108936402243
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,21486,137,0.85 [0.59-1.21],0.3626024096460754
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute peritonitis,22952,71,1.24 [0.84-1.84],0.275100477860168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22699,30,1.23 [0.69-2.18],0.4749630277176679
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,17830,298,1.14 [0.93-1.39],0.2115548591766386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21417,68,1.22 [0.82-1.82],0.3186299175859568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23077,68,1.23 [0.83-1.84],0.3079381120324018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,21499,150,0.74 [0.52-1.06],0.1004360359075223
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,22375,1026,0.99 [0.88-1.12],0.8985212734233701
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,17817,285,0.91 [0.72-1.16],0.4379864885194769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21383,34,0.54 [0.24-1.24],0.1463834555864616
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23370,63,0.91 [0.55-1.52],0.7243774570227552
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,22133,126,1.39 [1.07-1.81],0.0143962308432158
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Collagenous colitis,21817,94,1.41 [1.04-1.91],0.0271522626774908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23321,138,1.01 [0.73-1.40],0.9479790990696914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,23148,1449,1.02 [0.93-1.13],0.6646367801304682
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,21795,72,0.98 [0.62-1.56],0.937688204175014
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23127,49,0.87 [0.48-1.57],0.642647301106057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21797,74,0.93 [0.58-1.48],0.7575020424956008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,22724,200,1.00 [0.76-1.32],0.9914112137734606
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22055,2097,1.00 [0.92-1.09],0.9820563257098928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23312,157,1.12 [0.84-1.49],0.4284497131571636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,23354,685,1.07 [0.93-1.23],0.3568138541360612
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21482,3950,1.02 [0.96-1.09],0.4643240396169161
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23031,507,0.95 [0.79-1.13],0.5606252437135584
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23333,452,0.98 [0.82-1.18],0.8575004571516025
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22627,103,1.04 [0.71-1.51],0.8514290188263717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22495,54,0.70 [0.38-1.30],0.2550405565400285
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23185,1178,1.01 [0.90-1.13],0.888852862659858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of tongue,22501,91,1.11 [0.76-1.62],0.5814279644427383
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22712,1363,1.00 [0.90-1.11],0.9505132642913922
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19483,2732,1.07 [0.99-1.15],0.0697627159006517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,17647,115,1.09 [0.78-1.52],0.6329343168205392
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23392,96,1.02 [0.69-1.50],0.9232565238875046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23355,56,1.13 [0.70-1.83],0.6088725757039979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22750,81,1.03 [0.68-1.56],0.8895996359644216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16851,100,1.04 [0.71-1.52],0.830613023131723
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,18104,572,0.92 [0.78-1.09],0.3500694972158169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,17832,300,1.06 [0.85-1.31],0.6058903414005861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19927,2395,1.01 [0.94-1.09],0.7618769716213291
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17943,411,1.07 [0.90-1.29],0.4306488489207424
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18343,7184,1.02 [0.97-1.06],0.5124956710032744
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,22945,938,0.98 [0.87-1.12],0.7994640500093637
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22586,62,0.53 [0.29-0.98],0.0425197834435867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17579,1078,1.01 [0.90-1.14],0.8086360964692381
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22703,34,0.87 [0.42-1.81],0.7149066064586245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,22427,2469,1.00 [0.92-1.08],0.9613758595377112
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,23363,51,1.17 [0.72-1.91],0.5319936283527279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impaction of intestines,16810,59,1.17 [0.74-1.85],0.5077986400587946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,20104,146,1.13 [0.84-1.50],0.4212057600336906
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16835,84,0.99 [0.64-1.53],0.9659824465088368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22159,152,1.31 [1.02-1.70],0.0378505534092292
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17447,696,1.08 [0.94-1.24],0.2781944491423583
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23431,294,1.01 [0.81-1.25],0.949354615328712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22423,700,1.00 [0.86-1.16],0.9897587931140378
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22664,941,1.02 [0.90-1.15],0.8012082626421628
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17664,132,0.76 [0.52-1.11],0.155688312483193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,18024,492,1.07 [0.90-1.26],0.4492841603576747
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23399,142,1.21 [0.91-1.61],0.1916482757417245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20009,51,0.97 [0.57-1.66],0.9233367605906329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17809,1058,1.08 [0.96-1.21],0.1948296877138394
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21600,251,1.08 [0.86-1.36],0.5079480844837567
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21513,164,0.75 [0.53-1.05],0.0967662997879135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,18097,1346,1.07 [0.96-1.18],0.2092575933609856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,21597,4846,1.02 [0.96-1.07],0.559571783217124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22500,205,0.96 [0.72-1.26],0.7497509822389958
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23238,569,1.08 [0.93-1.26],0.3268952168977582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18038,506,1.15 [0.99-1.34],0.0643626118877681
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21483,134,1.04 [0.76-1.44],0.7905898768507588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23279,398,0.93 [0.76-1.14],0.4867453672538229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18457,925,1.08 [0.96-1.21],0.2173595168302618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22962,955,0.97 [0.86-1.10],0.6675328126589062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22674,150,1.12 [0.83-1.50],0.4537737839706774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18251,1500,1.04 [0.94-1.15],0.4346101051431922
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19329,1797,1.02 [0.94-1.12],0.59099732463108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22756,87,1.19 [0.83-1.70],0.3510172963419022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22554,831,1.04 [0.91-1.18],0.5891924148377432
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17034,283,0.98 [0.78-1.24],0.872337175618026
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23346,65,1.07 [0.68-1.70],0.7702136824111352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17173,422,0.98 [0.81-1.19],0.8401910094480716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22125,118,0.89 [0.61-1.30],0.534841554013322
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23432,66,0.96 [0.59-1.56],0.8746069440399771
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22524,118,0.89 [0.61-1.31],0.5638270026763288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Toxic colitis,21778,55,0.84 [0.48-1.48],0.5447098442376253
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17739,207,1.02 [0.78-1.32],0.9086935075293288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,21869,146,1.02 [0.74-1.40],0.8937986830893203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21845,122,0.98 [0.69-1.40],0.9295645819943106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,20108,150,1.02 [0.75-1.40],0.8861005547105174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16916,165,1.02 [0.76-1.38],0.8785708420268048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,20167,209,0.93 [0.70-1.22],0.5967297262099301
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Volvulus,16825,74,0.76 [0.46-1.28],0.3023941336088861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23367,211,1.25 [1.00-1.56],0.0478218217803088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23166,73,0.67 [0.39-1.14],0.1377449475231285
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21692,190,1.14 [0.88-1.47],0.3165356887966369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22969,536,0.96 [0.81-1.13],0.6196167337727457
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22561,128,1.14 [0.83-1.57],0.4031312323048188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21773,271,1.01 [0.81-1.27],0.9149429744372072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23171,241,1.01 [0.79-1.30],0.9164921811719602
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23342,412,1.11 [0.93-1.33],0.229079586560352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22972,42,0.62 [0.30-1.26],0.1877853271996416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22060,2703,1.06 [0.99-1.14],0.1035215004643997
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23046,406,1.27 [1.08-1.49],0.0036549554876228
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22918,278,1.22 [0.99-1.49],0.0571246630861022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23159,726,1.00 [0.86-1.15],0.948401426922745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23421,64,1.24 [0.82-1.87],0.3130912057512049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21588,86,1.30 [0.92-1.84],0.1395710601654347
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22680,40,1.39 [0.86-2.22],0.1748445505112919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23157,227,1.02 [0.79-1.32],0.8605338828405864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21853,351,1.09 [0.90-1.33],0.3577073589381851
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21548,46,1.24 [0.77-2.01],0.3760071769448583
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23348,67,1.54 [1.12-2.11],0.0072758364338387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22564,131,1.17 [0.86-1.58],0.316262569223964
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23242,149,1.15 [0.87-1.52],0.3395366606224791
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22972,42,1.58 [1.08-2.29],0.0169756143086275
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21557,55,0.73 [0.40-1.34],0.3143680950125995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22858,1356,1.07 [0.97-1.18],0.1846197557626556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21884,382,1.11 [0.93-1.34],0.2475397013175815
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21552,50,1.25 [0.79-1.98],0.3409524244229797
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23367,274,1.04 [0.83-1.30],0.7494477782676247
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23003,73,1.29 [0.89-1.88],0.176304684747898
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23306,213,1.00 [0.77-1.30],0.9980397944913412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23393,237,1.23 [1.00-1.52],0.0548760029593831
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21642,140,1.02 [0.74-1.40],0.9229453177681104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21727,225,1.05 [0.82-1.35],0.6995088267516669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23382,226,1.27 [1.03-1.57],0.0260918991454368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21673,171,1.07 [0.81-1.41],0.6360185788400485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23407,126,1.33 [1.01-1.74],0.0426067450368885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19998,113,0.92 [0.63-1.36],0.6844009279754885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21287,5459,0.99 [0.94-1.04],0.6091418840481231
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20100,4272,0.97 [0.91-1.03],0.2819079153091027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19950,65,1.22 [0.79-1.87],0.3672202613432853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20115,129,1.23 [0.91-1.66],0.1819032352077999
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20165,179,1.06 [0.80-1.41],0.6775886566942626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23197,98,0.94 [0.62-1.41],0.756234726918041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20086,100,0.86 [0.56-1.30],0.4635641277337659
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17019,1191,0.95 [0.85-1.06],0.3816949505540973
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23308,196,0.88 [0.66-1.18],0.4053769966629842
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20493,507,0.94 [0.79-1.13],0.5209898854237209
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19695,6957,1.02 [0.97-1.07],0.4203010230465525
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20992,116,0.88 [0.60-1.29],0.5022255353316668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20002,117,0.87 [0.59-1.28],0.4798779996787878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20476,591,1.02 [0.87-1.20],0.7781822759282985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22563,2577,0.99 [0.92-1.07],0.7882149736745453
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20037,152,1.01 [0.74-1.39],0.9360858595592724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20222,337,0.98 [0.79-1.21],0.8484366468727981
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20038,153,0.89 [0.64-1.24],0.4877008148971888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22589,94,1.18 [0.83-1.68],0.3443736319061514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17445,1617,1.05 [0.96-1.15],0.2900221848292242
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16004,176,1.34 [1.10-1.64],0.0040510205139305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23427,173,1.39 [1.12-1.72],0.0023671839444488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15921,93,0.88 [0.57-1.35],0.5648403881718081
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16324,496,0.96 [0.81-1.15],0.6881958300774763
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20174,289,1.00 [0.80-1.26],0.9880379424662188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16376,548,1.01 [0.86-1.19],0.8970696951040313
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20044,58,0.98 [0.59-1.63],0.9361967309866746
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20597,611,1.02 [0.88-1.19],0.7929766001271366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20272,286,1.07 [0.86-1.33],0.5200438926177269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16336,508,1.03 [0.87-1.21],0.7348778047764832
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19960,75,1.08 [0.70-1.67],0.7260260418799991
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19946,61,0.73 [0.41-1.30],0.2913814036207153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20921,45,1.18 [0.72-1.93],0.5046118867992977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23036,2160,1.05 [0.97-1.14],0.2540166108616119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22433,1557,1.05 [0.95-1.15],0.3267154488294128
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23262,509,0.99 [0.83-1.17],0.8746714460813882
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18434,2606,0.94 [0.87-1.02],0.1534905233444487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15890,62,0.61 [0.34-1.10],0.1030219389729998
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19975,90,1.33 [0.96-1.85],0.0899651431969669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15870,42,1.06 [0.60-1.85],0.8497178852489369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16006,178,1.13 [0.87-1.47],0.355394668014611
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21132,256,0.84 [0.64-1.09],0.1900892098680704
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21364,488,1.12 [0.95-1.31],0.1683321811245629
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23418,95,0.89 [0.59-1.35],0.5929813997122615
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21732,1746,1.00 [0.91-1.09],0.9262418510291994
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19997,112,1.08 [0.76-1.53],0.6805088712137728
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16028,200,1.07 [0.83-1.38],0.6083130771908902
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20686,700,1.01 [0.88-1.17],0.8704902303346773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18028,2200,1.01 [0.93-1.09],0.849263711441465
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22609,114,1.16 [0.84-1.61],0.357789801254524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23422,73,0.62 [0.36-1.07],0.0847305639273368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19950,65,1.51 [1.09-2.09],0.0143475714802095
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21153,1268,1.03 [0.93-1.15],0.5812503398497035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19957,72,0.80 [0.48-1.33],0.3996549747018406
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17530,1702,1.06 [0.97-1.16],0.1745312425975885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21004,128,0.70 [0.47-1.04],0.0744342855063006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19932,47,1.29 [0.81-2.05],0.2832922201683407
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20156,170,1.04 [0.78-1.38],0.7869881394779028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20377,492,1.15 [0.98-1.34],0.0942474136827777
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22937,442,1.10 [0.92-1.30],0.2939684391618782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20544,558,0.99 [0.84-1.16],0.8667082664502985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23274,492,1.01 [0.85-1.20],0.903688070041654
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23414,59,0.93 [0.56-1.57],0.7988133944491361
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20080,195,1.08 [0.83-1.40],0.5811348255009774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17958,785,1.06 [0.93-1.21],0.4093959189452689
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20453,568,1.04 [0.89-1.22],0.6004596918269882
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19989,104,0.82 [0.54-1.25],0.3583059568382845
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15898,70,1.23 [0.83-1.81],0.296248384181337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18082,2254,1.03 [0.95-1.11],0.4617788232977137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16546,718,1.08 [0.95-1.23],0.2432022407896328
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22747,252,1.10 [0.88-1.37],0.4175023291887889
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23392,69,0.95 [0.59-1.52],0.819064439606027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21472,47,1.05 [0.61-1.82],0.8514307492277144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15902,74,0.66 [0.39-1.12],0.1250948218145892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20084,98,0.92 [0.61-1.38],0.673976382309202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16341,513,0.98 [0.82-1.16],0.7942401170799454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20165,280,0.98 [0.77-1.24],0.8494357014837863
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20234,248,0.83 [0.64-1.08],0.1730979085854143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20226,240,1.11 [0.88-1.40],0.3679480861754458
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18069,74,0.73 [0.44-1.23],0.2411949247953927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23420,65,0.86 [0.51-1.44],0.5626248962891123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20432,547,1.01 [0.86-1.19],0.9020021404887963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22642,147,1.20 [0.91-1.59],0.2004168223782412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22307,2422,1.04 [0.97-1.13],0.259858239703416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20022,137,1.23 [0.92-1.63],0.1562815316097218
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20460,474,0.99 [0.83-1.18],0.8935671548549028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21926,221,1.10 [0.86-1.40],0.4497226334118397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20201,215,0.90 [0.68-1.18],0.4361516597439805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21462,1476,1.00 [0.90-1.10],0.951134582463078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20989,1003,1.06 [0.95-1.19],0.2921290285943203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19940,55,1.51 [1.04-2.19],0.0303425919066893
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22705,210,1.30 [1.04-1.62],0.0227065373206264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20054,169,1.11 [0.85-1.47],0.4393833705470642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20001,116,1.22 [0.89-1.66],0.2120916497961131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15871,43,1.23 [0.75-2.03],0.4181998145099177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22616,1008,1.08 [0.96-1.21],0.203705057053008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17561,87,1.44 [1.05-1.97],0.0222020283575608
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22849,97,1.12 [0.77-1.62],0.5494682115714353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23309,197,0.92 [0.69-1.22],0.5485249742433205
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23133,21,1.07 [0.50-2.29],0.866807145126617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22747,1139,1.13 [1.01-1.25],0.0255034948793869
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23301,55,1.21 [0.77-1.90],0.3992484927065495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23273,199,1.05 [0.81-1.36],0.7285499492198954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,20713,216,0.80 [0.60-1.07],0.1381718931612214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dialysis,21652,44,1.69 [1.20-2.39],0.0029058797957517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23025,273,0.94 [0.74-1.20],0.61343230483195
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,17623,149,1.30 [1.00-1.69],0.0499464557896238
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17808,334,1.02 [0.83-1.26],0.8273787040958194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18338,864,1.03 [0.91-1.17],0.6480394528217968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18232,4209,1.02 [0.96-1.08],0.5170856927175095
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23299,53,1.13 [0.68-1.86],0.6399542901529272
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21491,178,0.80 [0.58-1.10],0.1680595918847667
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22963,347,0.98 [0.79-1.21],0.8391823341357297
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23046,107,0.98 [0.67-1.44],0.9306932818732582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17735,261,1.02 [0.80-1.29],0.886638456910176
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20564,67,1.03 [0.65-1.62],0.9076791660980014
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19554,2080,1.01 [0.93-1.10],0.8064608806804554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17590,116,0.95 [0.65-1.38],0.7746699595229828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23432,56,0.68 [0.37-1.24],0.2075512104812081
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23431,66,0.82 [0.49-1.38],0.4531540572914959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22373,1876,0.99 [0.90-1.08],0.7879618446033444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20905,408,0.92 [0.75-1.12],0.3884487992082099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22847,95,0.94 [0.63-1.42],0.7700955913359535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23389,315,1.12 [0.92-1.37],0.2713486958790885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23388,73,1.14 [0.75-1.71],0.539304545837375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22102,1605,1.00 [0.91-1.10],0.9902454041433708
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22794,178,0.89 [0.65-1.21],0.4630050878479078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17607,133,1.11 [0.81-1.52],0.5051194576410507
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17803,329,1.07 [0.87-1.32],0.5262665070903124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17574,100,1.00 [0.68-1.47],0.985758896033443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17650,176,0.78 [0.56-1.09],0.1477339991846065
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21536,223,0.94 [0.72-1.23],0.6576982046988994
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23180,106,1.09 [0.77-1.56],0.6214683438243076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17737,263,1.04 [0.83-1.32],0.7144582861140532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17562,88,0.76 [0.47-1.21],0.2402656957911169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18013,539,1.24 [1.08-1.43],0.0031237045928477
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17612,138,0.82 [0.57-1.18],0.2833615898541597
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17968,494,1.02 [0.85-1.21],0.8607743247753008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23279,33,1.20 [0.65-2.21],0.5539674224632678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23291,1978,1.06 [0.98-1.15],0.1447053591854324
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21454,141,1.20 [0.91-1.60],0.196199680577687
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21689,81,1.44 [1.06-1.96],0.0195227641580067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23144,32,0.56 [0.24-1.30],0.180575387516311
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20618,121,1.09 [0.78-1.52],0.6206501705857841
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23338,226,0.91 [0.70-1.19],0.5034507279902407
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17592,118,1.29 [0.96-1.73],0.0864227968883751
